Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma

Cancer Research

Volumn 67, Issue 18, 2007, Pages 8900-8905

  Kryczek, Ilona ^a   Wei, Shuang ^a   Zhu, Gefeng ^b   Myers, Leann ^c   Mottram, Peter ^c   Cheng, Pui ^c   Chen, Lieping ^b   Coukos, George ^d   Zou, Weiping ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; B7 H4 ANTIGEN; CHEMOKINE; INTERLEUKIN 10; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOCRINE EFFECT; CANCER SURVIVAL; CELLULAR IMMUNITY; COCULTURE; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; KAPLAN MEIER METHOD; LYMPHOCYTE COUNT; MACROPHAGE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STATISTICAL ANALYSIS;

ANTIGEN-PRESENTING CELLS; ANTIGENS, CD80; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MACROPHAGES; OVARIAN NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 34548798737     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-1866     Document Type: Article

References (26)

1. Sica GL, Choi IH, Zhu G, et al. B7-4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003;18:849-61.
2. Zang X, Loke P, Kim J, Murphy K, Waitz R, Allison JP. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci U S A 2003;100: 10388-92.
3. Prasad DV, Richards S, Mai XM, Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003;18:863-73.
4. Choi IH, Zhu G, Sica GL, et al. Genomic organization and expression analysis of B7-4, an immune inhibitory molecule of the B7 family. J Immunol 2003;171:4650-4.
5. Kryczek I, Zou L, Rodriguez P, et al. B7-4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 2006;203:871-81.
6. Bignotti E, Tassi RA, Calza S, et al. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: Identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol 2006;103:405-16.
7. Tringler B, Liu W, Corral L, et al. B7-4 overexpression in ovarian tumors. Gynecol Oncol 2006;100:44-52.
8. Simon I, Zhuo S, Corral L, et al. B7-4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer. Cancer Res 2006;66: 1570-5.
9. Salceda S, Tang T, Kmet M, et al. The immunomodulatory protein B7-4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res 2005;306:128-41.
10. Sun Y, Wang Y, Zhao J, et al. B7-3 and B7-4 expression in non-small-cell lung cancer. Lung Cancer 2006;53:143-51.
11. Tringler B, Zhuo S, Pilkington G, et al. B7-4 is highly expressed in ductal and lobular breast cancer. Clin Cancer Res 2005;11:1842-8.
12. Krambeck AE, Thompson RH, Dong H, et al. B7-4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci U S A 2006;103:10391-6.
13. Wyckoff J, Wang W, Lin EY, et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004;64:7022-9.
14. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71-8.
15. Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth. Nat Rev Immunol 2004;4: 641-8.
16. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002;23:549-55.
17. Zou W, Machelon V, Coulomb-L'Hermin A, et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 2001;7:1339-46.
18. Curiel TJ, Coukos G, Zou L, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004;10:942-9.
19. Curiel TJ, Wei S, Dong H, et al. Blockade of B7-1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 2003;21:21.
20. Zou W, Durand-Gasselin I, Dulioust A, Maillot MC, Galanaud P, Emilie D. Quantification of cytokine gene expression by competitive PCR using a colorimetric assay. Eur Cytokine Netw 1995;6:257-64.
21. Kryczek I, Wei S, Zou L, et al. Cutting Edge: Induction of B7-4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol 2006;177:40-4.
22. Chen L. Co-inhibitory molecules of the B7-28 family in the control of T-cell immunity. Nat Rev Immunol 2004;4:336-47.
23. Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002;8: 793-800.
24. Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006;6:295-307.
25. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005;5:263-74.
26. + regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res 2004;64:8451-5.